1h Free Analyst Time
AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn's disease, cancer, and other serious health conditions. AbbVie is also advancing its pipeline programs for the treatment of Crohn's disease, Parkinson's disease, viral diseases, wet AMD, various cancers, neurological disorders, aesthetics, and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, healthcare facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses worldwide. AbbVie is headquartered in North Chicago, Illinois, the US.AbbVie Inc Key Recent Developments
- Jul 27, 2023: AbbVie Reports Second-Quarter 2023 Financial Results
- Jul 18, 2023: The Alliance for Genomic Discovery Announces Founding Biopharma Members: Abbvie, Amgen, Astrazeneca, Bayer, and Merck
- Jun 29, 2023: Lupin Announces Achievement of Key Milestone for Its Phase 1 Clinical Stage Malt 1 Inhibitor Program
- Jun 29, 2023: AbbVie : Robert A. Michael Has Been Appointed as President and Chief Operating Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Black Diamond Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- ADC Therapeutics SA
- Aptose Biosciences Inc
- Merck & Co Inc
- Quince Therapeutics Inc
- Takeda Pharmaceutical Co Ltd
- Kiniksa Pharmaceuticals Ltd
- Ainos Inc
- Gilead Sciences Inc
- Novartis AG
- Pfizer Inc
- Principia Biopharma Inc
- Repligen Corp
- Viracta Therapeutics Inc
- Ainos Inc
- Dicerna Pharmaceuticals Inc
- Gilead Sciences Inc
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Co
- Bristol-Myers Squibb Co
- Black Diamond Therapeutics Inc
- Takeda Pharmaceutical Co Ltd
- Processa Pharmaceuticals Inc
- Kiniksa Pharmaceuticals Ltd
- GSK plc
- Greenfire Bio LLC
- Fate Therapeutics Inc
- Arcutis Biotherapeutics Inc
- Quince Therapeutics Inc
- Merck & Co Inc
- Aptose Biosciences Inc
- Amgen Inc
- ADC Therapeutics SA
- Repligen Corp
- Principia Biopharma Inc
- Pfizer Inc
- Novartis AG
- Dicerna Pharmaceuticals Inc
- Amgen Inc
- GSK plc
- Greenfire Bio LLC
- Fate Therapeutics Inc
- Arcutis Biotherapeutics Inc
- Vincerx Pharma Inc
- Viracta Therapeutics Inc
- Processa Pharmaceuticals Inc
- Eli Lilly and Co
- Bristol-Myers Squibb Co